Debra Richman serves as Chief Development Officer at The Oncology Institute (NASDAQ: TOI), the nation’s leading provider of value-based oncology care. As Chief Development Officer, she directs The Oncology Institute’s national business and corporate development including strategy, M&A, payor and provider contracting, and new market and product expansion.Debra brings deep expertise in management, scaling revenue, developing, and executing growth-oriented strategic plans, forging accretive partnerships, and new market and product development across industry sectors, including payors, providers, consum...read more